Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Health Res Policy Syst ; 12: 3, 2014 Jan 17.
Artículo en Inglés | MEDLINE | ID: mdl-24438431

RESUMEN

BACKGROUND: The key to universal coverage in tuberculosis (TB) management lies in community participation and empowerment of the population. Social infrastructure development generates social capital and addresses the crucial social determinants of TB, thereby improving program performance. Recently, there has been renewed interest in the concept of social infrastructure development for TB control in developing countries. This study aims to revive this concept and highlight the fact that documentation on ways to operationalize urban TB control is required from a holistic development perspective. Further, it explains how development of social infrastructure impacts health and development outcomes, especially with respect to TB in urban settings. METHODS: A wide range of published Government records pertaining to social development parameters and TB program surveillance, between 2001 and 2011 in Delhi, were studied. Social infrastructure development parameters like human development index along with other indicators reflecting patient profile and habitation in urban settings were selected as social determinants of TB. These include adult literacy rates, per capita income, net migration rates, percentage growth in slum population, and percentage of urban population living in one-room dwelling units. The impact of the Revised National Tuberculosis Control Program on TB incidence was assessed as an annual decline in new TB cases notified under the program. Univariate linear regression was employed to examine the interrelationship between social development parameters and TB program outcomes. RESULTS: The decade saw a significant growth in most of the social development parameters in the State. TB program performance showed 46% increment in lives saved among all types of TB cases per 100,000 population. The 7% reduction in new TB case notifications from the year 2001 to 2011, translates to a logarithmic decline of 5.4 new TB cases per 100,000 population. Except per capita income, literacy, and net migration rates, other social determinants showed significant correlation with decline in new TB cases per 100,000 population. CONCLUSIONS: Social infrastructure development leads to social capital generation which engenders positive growth in TB program outcomes. Strategies which promote social infrastructure development should find adequate weightage in the overall policy framework for urban TB control in developing countries.


Asunto(s)
Política de Salud , Programas Nacionales de Salud/organización & administración , Cambio Social , Tuberculosis/prevención & control , Servicios Urbanos de Salud/organización & administración , Educación/estadística & datos numéricos , Emigración e Inmigración/estadística & datos numéricos , Política Ambiental , Femenino , Humanos , Incidencia , Relaciones Interinstitucionales , Masculino , Factores Socioeconómicos , Tuberculosis/epidemiología , Cobertura Universal del Seguro de Salud , Salud Urbana
2.
J Commun Dis ; 36(4): 251-9, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16506547

RESUMEN

A total of 8.37% of the 1195 patients treated at NDTB Centre with DOTS under RNTCP between January 2002 to June 2003 presented with adverse drug reactions. Patients showing any sort of adverse reactions were studied in detail by personal interviews and a semi-structured questionnaire. The profile of patients presenting with adverse reactions showed that majority of the patients (53%) had gastrointestinal reactions, the commonest presenting complaint being nausea and vomiting. General aches and pains were complained by about 35% and giddiness was the presenting complaint in 27% irrespective of the use of streptomycin, although giddiness was observed more often in Category II patients (59%). Skin rash and itching was complained by about 17% of patients and 11% complained of arthralgia, while only 1% had hepatotoxicity during treatment. Majority of the adverse reactions (67%) were observed within the first four weeks of treatment and only 0.25% of patients treated with DOTS had interruption of treatment for short periods.


Asunto(s)
Antituberculosos/efectos adversos , Terapia por Observación Directa , Tuberculosis/tratamiento farmacológico , Adolescente , Adulto , Antituberculosos/administración & dosificación , Antituberculosos/uso terapéutico , Esquema de Medicación , Quimioterapia Combinada , Etambutol/administración & dosificación , Etambutol/efectos adversos , Etambutol/uso terapéutico , Femenino , Humanos , India , Isoniazida/administración & dosificación , Isoniazida/efectos adversos , Isoniazida/uso terapéutico , Masculino , Persona de Mediana Edad , Programas Nacionales de Salud , Cooperación del Paciente , Pirazinamida/administración & dosificación , Pirazinamida/efectos adversos , Pirazinamida/uso terapéutico , Rifampin/administración & dosificación , Rifampin/efectos adversos , Rifampin/uso terapéutico , Estreptomicina/administración & dosificación , Estreptomicina/efectos adversos , Estreptomicina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA